Introduction Executive Summary Serotonin receptor 2 Agonist: Overview • Structure • Mechanism of Action Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Serotonin receptor 2 Agonist – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Serotonin receptor 2 Agonist companies’ collaborations, Licensing, Acquisition -Deal Value Trends Serotonin receptor 2 Agonist Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis Aripiprazole: Bristol Myers Squibb • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis Psilocybin: COMPASS Pathways • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Drug Name: Company Name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Serotonin receptor 2 Agonist Key Companies Serotonin receptor 2 Agonist Key Products Serotonin receptor 2 Agonist- Unmet Needs Serotonin receptor 2 Agonist- Market Drivers and Barriers Serotonin receptor 2 Agonist- Future Perspectives and Conclusion Serotonin receptor 2 Agonist Analyst Views Serotonin receptor 2 Agonist Key Companies Appendix

Table 1 Total Products for Serotonin receptor 2 Agonist Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Bristol Myers Squibb • Elusis Therapeutics • Eisai Co., Ltd • COMPASS pathways • Arena Pharmaceuticals